Market Place
Sourcing Support
Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments
This year has seen pivotal advancements in medical innovation. The US Food and Drug Administration (
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Compliance troubles emerge at Pfizer, Teva, Wockhardt and Xiamen Origin
It has been an
unprecedented week where compliance glitches have emerged from almost all parts
of t
